171 related articles for article (PubMed ID: 36540031)
1. Prevalence of cutaneous manifestations in COVID-19: A meta-analysis.
Li J; Wen W; Mu Z; Du X; Han X
J Dermatol; 2023 May; 50(5):622-636. PubMed ID: 36540031
[TBL] [Abstract][Full Text] [Related]
2. Early Cutaneous Manifestations of COVID-19: A Systematic Review and Public Health Implications.
Grover A; Choi F; Wang SP
WMJ; 2023 Dec; 122(5):349-356. PubMed ID: 38180923
[TBL] [Abstract][Full Text] [Related]
3. Epidemiology and clinical evolution of non-multisystem inflammatory syndrome (MIS-C) dermatological lesions in pediatric patients affected by SARS-CoV-2 infection: A systematic review of the literature.
Dondi A; Sperti G; Gori D; Guaraldi F; Montalti M; Parini L; Piraccini BM; Lanari M; Neri I
Eur J Pediatr; 2022 Oct; 181(10):3577-3593. PubMed ID: 35948654
[TBL] [Abstract][Full Text] [Related]
4. The trend of cutaneous lesions during COVID-19 pandemic: lessons from a meta-analysis and systematic review.
Rajan M B; Kumar-M P; Bhardwaj A
Int J Dermatol; 2020 Nov; 59(11):1358-1370. PubMed ID: 32936462
[TBL] [Abstract][Full Text] [Related]
5. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
6. Epidemiology, clinical profiles, and prognostic value of COVID-19-related cutaneous manifestations in African populations: a rapid narrative review.
Nyasulu PS; Tamuzi JL
Int J Dermatol; 2024 Jan; 63(1):10-22. PubMed ID: 37965793
[TBL] [Abstract][Full Text] [Related]
7. Cutaneous Manifestations of COVID-19: A Systematic Review.
Singh H; Kaur H; Singh K; Sen CK
Adv Wound Care (New Rochelle); 2021 Feb; 10(2):51-80. PubMed ID: 33035150
[No Abstract] [Full Text] [Related]
8. Pathobiology of Cutaneous Manifestations Associated with COVID-19 and Their Management.
Masood W; Ahmad S; Khan NA; Shakir A; Rokni GR; Gold MH; Cockerell CJ; Schwartz RA; Goldust M
Viruses; 2022 Sep; 14(9):. PubMed ID: 36146777
[TBL] [Abstract][Full Text] [Related]
9. Identification, Mechanism, and Treatment of Skin Lesions in COVID-19: A Review.
Fernández-Lázaro D; Garrosa M
Viruses; 2021 Sep; 13(10):. PubMed ID: 34696346
[TBL] [Abstract][Full Text] [Related]
10. Pernio-like skin lesions associated with COVID-19: A case series of 318 patients from 8 countries.
Freeman EE; McMahon DE; Lipoff JB; Rosenbach M; Kovarik C; Takeshita J; French LE; Thiers BH; Hruza GJ; Fox LP;
J Am Acad Dermatol; 2020 Aug; 83(2):486-492. PubMed ID: 32479979
[TBL] [Abstract][Full Text] [Related]
11. Dermatopathology of COVID-19 infection and vaccination.
Fernández-Figueras MT
Pathologie (Heidelb); 2022 Aug; 43(Suppl 1):114-118. PubMed ID: 36197514
[TBL] [Abstract][Full Text] [Related]
12. "COVID toes": A meta-analysis of case and observational studies on clinical, histopathological, and laboratory findings.
Rocha KO; Zanuncio VV; Freitas BAC; Lima LM
Pediatr Dermatol; 2021 Sep; 38(5):1143-1149. PubMed ID: 34515379
[TBL] [Abstract][Full Text] [Related]
13. Cutaneous Manifestations in the Context of SARS-CoV-2 Infection (COVID-19).
Carrascosa JM; Morillas V; Bielsa I; Munera-Campos M
Actas Dermosifiliogr (Engl Ed); 2020 Nov; 111(9):734-742. PubMed ID: 32882184
[TBL] [Abstract][Full Text] [Related]
14. Are the chilblain-like lesions observed during the COVID-19 pandemic due to severe acute respiratory syndrome coronavirus 2? Systematic review and meta-analysis.
Sánchez-García V; Hernández-Quiles R; de-Miguel-Balsa E; Docampo-Simón A; Belinchón-Romero I; Ramos-Rincón JM
J Eur Acad Dermatol Venereol; 2022 Jan; 36(1):24-38. PubMed ID: 34545625
[TBL] [Abstract][Full Text] [Related]
15. Cutaneous manifestations of COVID-19.
Wang CJ; Worswick S
Dermatol Online J; 2021 Jan; 27(1):. PubMed ID: 33560783
[TBL] [Abstract][Full Text] [Related]
16. [Cutaneous Manifestations Associated with COVID-19: A Narrative Review].
Relvas M; Calvão J; Oliveira R; Cardoso JC; Gonçalo M
Acta Med Port; 2021 Feb; 34(2):128-136. PubMed ID: 33315008
[TBL] [Abstract][Full Text] [Related]
17. Cutaneous manifestations of COVID-19 and COVID-19 vaccination.
Nakashima C; Kato M; Otsuka A
J Dermatol; 2023 Mar; 50(3):280-289. PubMed ID: 36636825
[TBL] [Abstract][Full Text] [Related]
18. Clinical Patterns and Morphology of COVID-19 Dermatology.
Agnihothri R; Fox LP
Dermatol Clin; 2021 Oct; 39(4):487-503. PubMed ID: 34556240
[TBL] [Abstract][Full Text] [Related]
19. Covid-19 skin manifestations: an update.
Sanchez-Flores X; Huynh T; Huang JT
Curr Opin Pediatr; 2021 Aug; 33(4):380-386. PubMed ID: 34127574
[TBL] [Abstract][Full Text] [Related]
20. Cutaneous manifestations in hospitalized patients diagnosed as COVID-19.
Askin O; Altunkalem RN; Altinisik DD; Uzuncakmak TK; Tursen U; Kutlubay Z
Dermatol Ther; 2020 Nov; 33(6):e13896. PubMed ID: 32579756
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]